valine has been researched along with Angiogenesis, Pathologic in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 10 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cha, H; Cho, WJ; Dung, le TK; Lee, HY; Lee, SJ; Min, YJ; Moon, CH; Park, JW | 1 |
| Giddabasappa, A; Goodman, J; Lappin, PB; Lee, J; Levkoff, T; Li, G; Nichols, T; Painter, CL; Pascual, B; Simmons, B; Xie, Z; Yan, Z; Zhang, CC; Zhang, Q | 1 |
| Chung, JW; Kim, DH; Kim, KW; Kim, SJ; Kim, YI; Lee, HK; Lee, JM; Park, J; Tseng, JC; Youn, H | 1 |
| Choi, BI; Han, JK; Joo, I; Lee, JM | 1 |
| Aymerich, M; Campo, E; Colomer, D; López-Guerra, M; López-Otín, C; Matas-Céspedes, A; Montraveta, A; Pérez-Galán, P; Roldán, J; Rosich, L; Roué, G; Villamor, N; Xargay-Torrent, S | 1 |
| Koh, DM | 1 |
| Birrane, G; Cooke, VG; Eikesdal, HP; Kalluri, R; Kieran, M; Maeshima, Y; Sugimoto, H | 1 |
| Harbig, J; Jaworski, K; Miller, AG; Tan, G; Wilkinson-Berka, JL | 1 |
| Banquerigo, ML; Brahn, E; Lee, S; Schoettler, N | 1 |
| Ashraf, S; Mapp, PI; Walsh, DA | 1 |
| Boulton, ME; Boye, SL; Cai, J; Chen, Z; Grant, MB; Han, S; Hauswirth, WW; Liu, L; Qi, X; Ruan, Q | 1 |
| Dai, W; Li, RT; Liang, L; Lin, SW; Lu, JK; Xiang, Y; Yang, TY; Zhang, Q; Zhang, Y | 1 |
| Choi, BI; Choi, Y; Han, JK; Jeon, YS; Kiefer, B; Kim, C; Kim, KW; Lee, IJ; Lee, JM; Park, J | 1 |
| Akino, M; Chiba, S; Kitabatake, A; Kumamoto, H; Matsui, Y; Mikami, T; Nan, J; Okamoto, H; Onozuka, H; Shimizu, T; Sugawara, T | 1 |
| Brahn, E; Lainer-Carr, D | 1 |
| Bainbridge, J; Binks, M; Essex, D; Madden, L; Malhotra, R; Paleolog, EM | 1 |
1 review(s) available for valine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Angiogenesis inhibition as a therapeutic approach for inflammatory synovitis.
Topics: Angiopoietins; Cyclohexanes; Epoxy Compounds; Fatty Acids, Unsaturated; Humans; Hypoxia-Inducible Factor 1; Integrin alphaVbeta3; Neovascularization, Pathologic; O-(Chloroacetylcarbamoyl)fumagillol; Receptor, TIE-2; Sesquiterpenes; Synovitis; Tubulin Modulators; Valine; Vascular Endothelial Growth Factor A | 2007 |
15 other study(ies) available for valine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
CKD-516 displays vascular disrupting properties and enhances anti-tumor activity in combination with chemotherapy in a murine tumor model.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzophenones; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Deoxycytidine; Female; Gemcitabine; Human Umbilical Vein Endothelial Cells; Humans; Mice, Mutant Strains; Microtubules; Neoplasms; Neovascularization, Pathologic; Tubulin; Tumor Burden; Valine; Xenograft Model Antitumor Assays | 2014 |
Comparison of dynamic contrast-enhanced MR, ultrasound and optical imaging modalities to evaluate the antiangiogenic effect of PF-03084014 and sunitinib.
Topics: Amyloid Precursor Protein Secretases; Angiogenesis Inhibitors; Cell Line, Tumor; Contrast Media; Humans; Indoles; Magnetic Resonance Imaging; Molecular Imaging; Neovascularization, Pathologic; Pyrroles; Radiography; Sunitinib; Tetrahydronaphthalenes; Ultrasonography; Valine; Xenograft Model Antitumor Assays | 2014 |
Enhanced efficacy of CKD-516 in combination with doxorubicin: pre-clinical evaluation using a hepatocellular carcinoma xenograft model.
Topics: Animals; Apoptosis; Benzophenones; Carcinoma, Hepatocellular; Cell Line, Tumor; Disease Models, Animal; Doxorubicin; Drug Evaluation, Preclinical; Drug Synergism; Humans; Liver Neoplasms; Mice; Necrosis; Neovascularization, Pathologic; Tumor Burden; Valine; Xenograft Model Antitumor Assays | 2014 |
Intravoxel incoherent motion diffusion-weighted MR imaging for monitoring the therapeutic efficacy of the vascular disrupting agent CKD-516 in rabbit VX2 liver tumors.
Topics: Angiogenesis Inhibitors; Animals; Benzophenones; Diffusion Magnetic Resonance Imaging; Image Enhancement; Liver Neoplasms, Experimental; Male; Neovascularization, Pathologic; Rabbits; Random Allocation; Valine | 2014 |
The γ-secretase inhibitor PF-03084014 combined with fludarabine antagonizes migration, invasion and angiogenesis in NOTCH1-mutated CLL cells.
Topics: Aged; Amyloid Precursor Protein Secretases; Enzyme Inhibitors; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Mutation; Neoplasm Invasiveness; Neoplasm Metastasis; Neovascularization, Pathologic; Receptor, Notch1; Tetrahydronaphthalenes; Tumor Cells, Cultured; Valine; Vidarabine | 2015 |
Science to practice: can intravoxel incoherent motion diffusion-weighted MR imaging be used to assess tumor response to antivascular drugs?
Topics: Angiogenesis Inhibitors; Animals; Benzophenones; Diffusion Magnetic Resonance Imaging; Liver Neoplasms, Experimental; Neovascularization, Pathologic; Rabbits; Valine | 2014 |
Identification of amino acids essential for the antiangiogenic activity of tumstatin and its use in combination antitumor activity.
Topics: Amino Acid Substitution; Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Autoantigens; Bevacizumab; Carcinoma, Renal Cell; Cell Proliferation; Cells, Cultured; Collagen Type IV; Endothelial Cells; Humans; Integrin alphaVbeta3; Kidney Neoplasms; Leucine; Mice; Mice, Inbred C57BL; Mutagenesis, Site-Directed; Neoplasm Transplantation; Neovascularization, Pathologic; Protein Conformation; Valine; Xenograft Model Antitumor Assays | 2008 |
Identification of a retinal aldosterone system and the protective effects of mineralocorticoid receptor antagonism on retinal vascular pathology.
Topics: Aldosterone; Angiogenesis Inhibitors; Angiotensin II Type 1 Receptor Blockers; Animals; Cattle; Cells, Cultured; Cytokines; Endothelial Cells; Eye Proteins; Glucosephosphate Dehydrogenase; Leukostasis; Mineralocorticoid Receptor Antagonists; NADPH Oxidase 4; NADPH Oxidases; Neovascularization, Pathologic; Oxidative Stress; Oxygen; Pericytes; Rats; Rats, Sprague-Dawley; Receptors, Mineralocorticoid; Renin-Angiotensin System; Retinal Vasculitis; Sodium Chloride; Spironolactone; Tetrazoles; Valine; Valsartan; Vascular Endothelial Growth Factor A | 2009 |
Involution of collagen-induced arthritis with an angiogenesis inhibitor, PPI-2458.
Topics: Administration, Oral; Angiogenesis Inhibitors; Animals; Arthritis, Experimental; Biological Availability; Collagen Type II; Epoxy Compounds; Flow Cytometry; Injections, Intravenous; Injections, Subcutaneous; Molecular Structure; Neovascularization, Pathologic; Rats; Rats, Inbred Strains; Valine | 2009 |
Angiogenesis and the persistence of inflammation in a rat model of proliferative synovitis.
Topics: Angiogenesis Inhibitors; Animals; Carrageenan; Cell Proliferation; Disease Models, Animal; Drug Therapy, Combination; Endothelium, Vascular; Epoxy Compounds; Fibroblast Growth Factor 2; Hindlimb; Injections, Intra-Articular; Joints; Macrophages; Male; Neovascularization, Pathologic; Rats; Rats, Wistar; Synovial Membrane; Synovitis; Valine | 2010 |
γ-Secretase and presenilin mediate cleavage and phosphorylation of vascular endothelial growth factor receptor-1.
Topics: Alanine; Amino Acid Sequence; Amyloid Precursor Protein Secretases; Animals; Cattle; Eye Proteins; Intercellular Signaling Peptides and Proteins; Microcirculation; Molecular Sequence Data; Mutagenesis, Site-Directed; Neovascularization, Pathologic; Nerve Growth Factors; Phosphorylation; Presenilin-1; Protein Tyrosine Phosphatases; Retina; RNA, Small Interfering; Serpins; Valine; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1 | 2011 |
Novel cathepsin B-sensitive paclitaxel conjugate: Higher water solubility, better efficacy and lower toxicity.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cathepsin B; Cell Cycle; Cell Line, Tumor; Citrulline; Dipeptides; Female; Humans; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neoplasms; Neovascularization, Pathologic; Paclitaxel; Polyethylene Glycols; Tumor Burden; Valine | 2012 |
Vascular disrupting effect of CKD-516: preclinical study using DCE-MRI.
Topics: Animals; Antineoplastic Agents; Benzophenones; Cells, Cultured; Human Umbilical Vein Endothelial Cells; Humans; Magnetic Resonance Imaging; Neoplasms, Muscle Tissue; Neovascularization, Pathologic; Rabbits; Tubulin; Tubulin Modulators; Valine | 2013 |
VEGF-mediated angiogenesis is impaired by angiotensin type 1 receptor blockade in cardiomyopathic hamster hearts.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomyopathies; Cricetinae; Enalapril; Endothelial Growth Factors; Intercellular Signaling Peptides and Proteins; Lymphokines; Male; Neovascularization, Pathologic; Receptor, Angiotensin, Type 1; RNA, Messenger; Tetrazoles; Time Factors; Valine; Valsartan; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2003 |
Methionine aminopeptidase-2 blockade reduces chronic collagen-induced arthritis: potential role for angiogenesis inhibition.
Topics: Aminopeptidases; Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Cell Proliferation; Cells, Cultured; Endothelial Cells; Epoxy Compounds; Fibroblast Growth Factor 2; Glycoproteins; Humans; Male; Methionyl Aminopeptidases; Mice; Mice, Inbred DBA; Neovascularization, Pathologic; Protease Inhibitors; Synovial Membrane; Valine; Vascular Endothelial Growth Factor A | 2007 |